Predicting ACI Outcomes with GMP In-Process Control Kinetic Metrics: Initial Chondrocyte Yield and Population Doubling Time as Prognostic Clinical Biomarkers.

Philippe V, Laurent AE, Berchtold A, Hirt-Burri N, Applegate LA, Martin R.

Open source

DOI
10.3390/life16081297
Published
2026-08-06
Container
Life (Basel)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life16081297,
  title = {Predicting ACI Outcomes with GMP In-Process Control Kinetic Metrics: Initial Chondrocyte Yield and Population Doubling Time as Prognostic Clinical Biomarkers.},
  author = {Philippe V and  Laurent AE and  Berchtold A and  Hirt-Burri N and  Applegate LA and  Martin R.},
  year = {2026},
  journal = {Life (Basel)},
  doi = {10.3390/life16081297},
  url = {https://doi.org/10.3390/life16081297}
}

RIS

TY  - JOUR
TI  - Predicting ACI Outcomes with GMP In-Process Control Kinetic Metrics: Initial Chondrocyte Yield and Population Doubling Time as Prognostic Clinical Biomarkers.
AU  - Philippe V
AU  -  Laurent AE
AU  -  Berchtold A
AU  -  Hirt-Burri N
AU  -  Applegate LA
AU  -  Martin R.
PY  - 2026
JO  - Life (Basel)
DO  - 10.3390/life16081297
UR  - https://doi.org/10.3390/life16081297
ER  - 

APA

V, P., AE, L., A, B., N, H., LA, A., & R., M. (2026). Predicting ACI Outcomes with GMP In-Process Control Kinetic Metrics: Initial Chondrocyte Yield and Population Doubling Time as Prognostic Clinical Biomarkers.. Life (Basel). https://doi.org/10.3390/life16081297

Source records